Search results

Filter

Filetype

Your search for "*" yielded 128680 hits

Thesis Defence Interview - Sara Nolbrant

Sara Nolbrant, from the Developmental and Regenerative Neurobiology lab, will be defending her PhD thesis on Friday 31st of January. Researching in the group led by Malin Parmar, Sara has been directing and dissecting the fate of dopaminergic neurons with the aim developing cell replacement therapy for the treatment of Parkinson’s disease. Here, Sara answers a few questions about her research and

https://www.regenerative-neurobiology.lu.se/article/thesis-defence-interview-sara-nolbrant - 2025-12-21

Thesis Defence Interview – Marcella Birtele

Marcella Birtele will be defending her PhD thesis titled “Functional and Transcriptional Studies of Human Dopaminergic Neurons” on Friday 2nd October. Researching within the Developmental and Regenerative Neurobiology group led by Prof. Malin Parmar, here Marcella tells us about her PhD studies at Lund Stem Cell Center.For full article please click on teh follwing link: Thesis Defence Interview –

https://www.regenerative-neurobiology.lu.se/article/thesis-defence-interview-marcella-birtele - 2025-12-21

PhD defence interview - Shelby Shrigley

During her PhD studies Shelby Shrigley has been exploring patient-specific cell replacement therapy for Parkinson's disease. Defending her PhD thesis on March 12th, here Shelby tells us about her research within the Developmental and Regenerative Neurobiology research group led by Prof. Malin Parmar and her time spent at Lund Stem Cell Center. For the full interview, please click here: https://www

https://www.regenerative-neurobiology.lu.se/article/phd-defence-interview-shelby-shrigley-0 - 2025-12-21

Malin Parmar & Anna Falk awarded a 5-year grant from Vinnova

Vinnova is Sweden's innovation agency with the mission to build Sweden’s innovation capacity. Earlier this year they announced a call for projects aiming to establish “Innovative environments for precision medicine” and last week they announced that the Lund-based project IndiCell is one of the funded projects. IndiCell is a collaborative project designed to connect academia, hospitals and industr

https://www.regenerative-neurobiology.lu.se/article/malin-parmar-anna-falk-awarded-5-year-grant-vinnova - 2025-12-21

Malin Parmar awarded a Distinguished professor grant within medicine and health

We are very happy and proud to announce that Malin Parmar has been awarded a 10-year Distinguished professor grant from the Swedish Research Council! The aim of the distinguished professor programme is to create conditions for the most prominent researchers to conduct long-term, ground-breaking research with great potential for achieving scientific breakthroughs. The grant shall also enable the es

https://www.regenerative-neurobiology.lu.se/article/malin-parmar-awarded-distinguished-professor-grant-within-medicine-and-health - 2025-12-21

Malin Parmar becomes a new member of The Royal Swedish Academy of Sciences

Nya ledamöter studerar Parkinsons sjukdom / New members of the class for medical sciences. For more inforamtion please click on the below links: På Svenska: https://www.kva.se/nyheter/nya-ledamoter-studerar-parkinsons-sjukdom/ Lunds universitet: https://www.medicin.lu.se/artikel/lundaprofessor-invald-i-kungliga-vetenskapsakademien In English: https://www.kva.se/en/news/new-members-of-the-class-for

https://www.regenerative-neurobiology.lu.se/article/malin-parmar-becomes-new-member-royal-swedish-academy-sciences - 2025-12-21

From enemy to friend – 33 million for reprogramming cancer cells

An international research project led from Lund University is now awarded 33 million SEK by the European Innovation Council, EIC Pathfinder. The idea behind the project is to use drugs to reprogram cancer cells into immune cells, in order to increase the body's natural anti-tumor response and fight cancer. And it is small molecules that will do the work. The research project that has received fund

https://www.medicine.lu.se/article/enemy-friend-33-million-reprogramming-cancer-cells - 2025-12-21

Eric K. Fernström Nordic Prize 2023 awarded to cancer researcher

Cancer researcher Harald Stenmark, professor at the University of Oslo and Oslo University Hospital, is the recipient of this year’s prize. Harald Stenmark is being recognised for his groundbreaking research in cell biology, in which he has elucidated in detail the functions of proteins essential for the regulation of endosomes and cell division of significance to cancer. Harald Stenmark’s researc

https://www.medicine.lu.se/article/eric-k-fernstrom-nordic-prize-2023-awarded-cancer-researcher - 2025-12-21

Research on inherited type 2 diabetes is awarded

How do heritability and the fetal environment affect the risk for the child to develop type 2 diabetes? This is a question that Rashmi Prasad studies in her research projects that that may lead to individualised prevention measures. She will be awarded this year’s recipient Medeon stipend on the World Diabetes Day Skåne event on November 14. Diabetes researcher Rashmi Prasad at Lund University Dia

https://www.medicine.lu.se/article/research-inherited-type-2-diabetes-awarded - 2025-12-21

The cancer researcher and the intelligence expert

David Gisselsson Nord and Tony Ingesson both love spy novels and have a nerdy interest in history. Their shared curiosity resulted in an interdisciplinary collaboration about how it might be possible to inspire smarter cancer treatment with the help of methods from espionage and intelligence analysis. Tony Ingesson finds it fairly easy to show a bit of attitude in front of the camera. David Gissel

https://www.medicine.lu.se/article/cancer-researcher-and-intelligence-expert - 2025-12-21

Children with breath-holding spells undergo unnecessary diagnostic interventions

Breath-holding spells are common in young children and are benign. Yet children often undergo unnecessary diagnostic interventions when seeking medical care. This is because there are no national or international guidelines on how to assess children in these cases. A team of researchers at Lund University, Sweden has now proposed guidelines to reduce the number of emergency and unplanned medical v

https://www.medicine.lu.se/article/children-breath-holding-spells-undergo-unnecessary-diagnostic-interventions - 2025-12-21

New study: Lost brain function restored after stroke

Researchers have succeeded in restoring lost brain function in mouse models of stroke using small molecules that in the future could potentially be developed into a stroke therapy. “Communication between nerve cells in large parts of the brain changes after a stroke and we show that it can be partially restored with the treatment", says Tadeusz Wieloch, senior professor at Lund University who led

https://www.medicine.lu.se/article/new-study-lost-brain-function-restored-after-stroke - 2025-12-21

Researchers have found the genetic cause for a type of hereditary ataxia, SCA4 – for long an unresolved conundrum

Intensive efforts are being made in medical research to discover the genomic causes of undiagnosed hereditary diseases. Persistent work and new technology are providing answers to several previously unsolved, enigmatic neurological disorders. Spinocerebellar ataxia type 4 was one of these, but now a research team in Lund, Sweden, have identified the gene that is responsible. Almost half a million

https://www.medicine.lu.se/article/researchers-have-found-genetic-cause-type-hereditary-ataxia-sca4-long-unresolved-conundrum - 2025-12-21

Exploring Genomic Dark Matter: Christopher Douse Awarded $1.2M Grant by Chan Zuckerberg Initiative

Christopher Douse, a new group leader at the Faculty of Medicine at Lund University, has been awarded the Ben Barres Early Career Acceleration Award by The Chan Zuckerberg Initiative. This award includes a $1.2 million grant to support his lab’s exploration of the repetitive portion of the human genome, so-called ‘genomic dark matter’, and its role in human brain development and degeneration. Repe

https://www.medicine.lu.se/article/exploring-genomic-dark-matter-christopher-douse-awarded-12m-grant-chan-zuckerberg-initiative - 2025-12-21